digital therapeutics

The firm plans to expand its chronic disease treatments across more therapeutic areas.

Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.

The company said it will use the financing to expand in Europe and the U.S., and develop new digital therapeutics with its pharma partners.

The partnership with Zuellig Pharma includes Ensemble, Happify's therapeutic for treating major depressive disorder and generalized anxiety disorder, and a prescription digital therapeutic for chronic insomnia.

Big Health's new chief commercial officer discusses her new role, what she's learned from her background in digital health and how to make it easy for patients to access digital therapeutics.

Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

Pharma companies continue to team up with startups and invest in AI for drug discovery. 

Healthcare professionals other than physicians, dentists and veterinarians who have prescribing authority under state law can order prescription digital therapeutics. That could improve access, especially to devices that treat mental health conditions.

The digital therapeutics industry must conduct and publish rigorous, replicable research if it is to truly become a legitimate option alongside in-person cognitive behavioral therapy and medications.